BRIEF published on 08/24/2026 at 08:05, 29 days 10 hours ago Valerio Therapeutics Acquires Etherna and Secures Financing Valerio Therapeutics Etherna Immunotherapies RNA Therapeutics Acquisition PIPE Financing Biotech Integration
PRESS RELEASE published on 08/24/2026 at 08:00, 29 days 10 hours ago Inside Information / Operations of the issuer (acquisitions, sales...) Valerio Therapeutics announces acquisition of Etherna Immunotherapies for €30 million enterprise value and €40.25 million PIPE financing. Shareholder approval secured Acquisition Valerio Therapeutics RNA Therapeutics Etherna Immunotherapies PIPE Financing
BRIEF published on 07/16/2026 at 09:12, 2 months 6 days ago Valerio Therapeutics Partners with Abivax for RNA Therapeutics Development Biotechnology Valerio Therapeutics Pipelines RNA Therapeutics Abivax Collaboration
BRIEF published on 07/16/2026 at 09:12, 2 months 6 days ago Valerio Therapeutics and Abivax join forces for innovative therapies Abivax Collaboration Inflammatory Diseases Valerio Therapeutics RNA Therapies
PRESS RELEASE published on 07/16/2026 at 09:07, 2 months 6 days ago Inside Information / Other news releases Valerio Therapeutics partners with Abivax for global collaboration, providing pipeline update on RNA therapeutics. Initial payment up to €2.4 million Abivax Collaboration Valerio Therapeutics Pipeline Update RNA Therapeutics
BRIEF published on 07/01/2026 at 09:27, 2 months 21 days ago Valerio Therapeutics is preparing to acquire Etherna Immunotherapies Valerio Therapeutics Biotechnology Investment Etherna Acquisition RNA Drugs Mergers Of Companies
BRIEF published on 07/01/2026 at 09:27, 2 months 21 days ago Valerio Therapeutics Proposes to Acquire Etherna Immunotherapies Biotechnology Valerio Therapeutics Acquisition Deal RNA Medicines Etherna Immunotherapies
PRESS RELEASE published on 07/01/2026 at 09:22, 2 months 21 days ago Inside Information / Other news releases Valerio Therapeutics announces binding offer to acquire Etherna Immunotherapies, creating global leader in targeted RNA medicines. Strategic move unlocked by leading investors Acquisition Valerio Therapeutics RNA Medicines Targeted Delivery Etherna Immunotherapies
BRIEF published on 06/16/2026 at 19:48, 3 months 5 days ago Valerio Therapeutics Appoints New CEO and Confirms AGM Resolutions Biotechnology CEO Transition Valerio Therapeutics Gilles Besin RNA Medicines
PRESS RELEASE published on 06/16/2026 at 19:43, 3 months 5 days ago Inside Information / Other news releases Valerio Therapeutics appoints Gilles Besin as CEO, approved all resolutions at annual general meeting. Besin brings deep RNA and targeted delivery expertise to drive innovation Annual General Meeting Valerio Therapeutics Gilles Besin RNA Medicines Targeted Delivery
Published on 09/22/2026 at 17:00, 1 hour 28 minutes ago Leggett Dynamics Expands Asia Pacific Headquarters
Published on 09/22/2026 at 16:30, 1 hour 58 minutes ago Formation Metals Intersects 0.98 g/t Au over 95.6 Metres Starting 7 Metres Below Surface, Including 3.14 g/t Au over the First 10 Metres, Extending the A-Zone Up to 50 Metres North at N2
Published on 09/22/2026 at 15:25, 3 hours 3 minutes ago Aztec Minerals Announces Closing of Upsized C$6.4 Million Bought Deal Private Placement Including Concurrent Exercise of Underwriter's Option
Published on 09/22/2026 at 15:20, 3 hours 8 minutes ago MicroVision Introduces Advanced Photonics Technology for Next-Generation AI Data Center Scale-Up Architecture
Published on 09/22/2026 at 17:45, 43 minutes ago Carvolix submits 510(k) for TAVIPILOT Robot, advancing toward US commercial launch of Its Integrated TAVIPILOT Platform.
Published on 09/22/2026 at 17:40, 48 minutes ago VALBIOTIS SA: Valbiotis announces positive results from the Cardio-Liver clinical study - Commercial launch of ValbiotisPRO® Foie on September 23
Published on 09/22/2026 at 17:20, 1 hour 8 minutes ago Perform.AI Launches AI Commerce Operating System
Published on 09/22/2026 at 17:10, 1 hour 18 minutes ago THE NATURAL DIAMOND COUNCIL RELAUNCHES AS THE DIAMOND COLLECTIVE WITH A NEW STRATEGY TO REIGNITE DESIRE FOR NATURAL DIAMONDS
Published on 09/22/2026 at 16:59, 1 hour 29 minutes ago Booster Precision Components Holding GmbH announces the successful completion of its Written Procedure to amend certain terms under the terms and conditions of the Bonds
Published on 09/22/2026 at 18:00, 28 minutes ago Consolidated results for the first half of 2026 EBITDA : 60,5 M€
Published on 09/22/2026 at 17:45, 43 minutes ago Imerys-09-2026-information-share-capital-and-voting-rights-as-of-31-August-2026
Published on 09/21/2026 at 18:19, 1 day ago Reporting on share buyback transactions carried out between September 14 and September 18, 2026
Published on 09/21/2026 at 18:01, 1 day ago Partnership agreement signed between Manitou Group and HD Construction Equipment
